TNF and infection: Our observed anti-tumoural role of TNF-alpha during ZIKV oncolysis, its reported antiviral property, and our in silico prediction of its involvement in anti-tumoural immune responses highlight that oZIKV infection could likely be augmented by adjuvant therapy targeting TNF-alpha.